Name | Human IL-3 Quantikine ELISA Kit |
---|---|
Supplier | R&D Systems |
Catalog | D3000 |
Category | ELISA Kit |
Prices | $509.00 |
Sizes | 1 kit |
Assay Type | Solid Phase Sandwich ELISA |
Sample Type | Cell Culture Supernates (200 uL), Serum (200 uL), EDTA Plasma (200 uL), Heparin Plasma (200 uL), Citrate Plasma (200 uL) |
Sensitivity | 7.4 pg/mL |
Range | 31.2 - 2,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma) |
Format | 96-well strip plate |
Applications | ELISA |
Species Reactivities | Human |
Description | The Quantikine Human IL-3 Immunoassay is a 4.5 hour solid phase ELISA designed to measure IL-3 in cell culture supernates, serum, and plasma |
Gene | IL3 |
Supplier Page | Shop |
Szygula Z, Lubkowska A, Giemza C, Skrzek A, Bryczkowska I, Dolegowska B. PLoS One. 2014 Apr 2;9(4):e93096.
Zheng MM, Zhang Z, Bemis K, Belch AR, Pilarski LM, Shively JE, Kirshner J. PLoS One. 2013;8(3):e58504.
Donhauser N, Pritschet K, Helm M, Harrer T, Schuster P, Ries M, Bischof G, Vollmer J, Smola S, Schmidt B. PLoS One. 2012;7(3):e33925.
Sadeghi M, Daniel V, Schnitzler P, Lahdou I, Naujokat C, Zeier M, Opelz G. Transplantation. 2009 Nov 15;88(9):1109-16.
Rudolph T, Schaps KP, Steven D, Koester R, Rudolph V, Berger J, Terres W, Meinertz T, Kaehler J. Int J Cardiol. 2009 Mar 6;132(3):392-7.
Schuster C, Vaculik C, Fiala C, Meindl S, Brandt O, Imhof M, Stingl G, Eppel W, Elbe-Burger A. J Exp Med. 2009 Jan 16;206(1):169-81.
Chauhan D, Singh AV, Brahmandam M, Carrasco R, Bandi M, Hideshima T, Bianchi G, Podar K, Tai YT, Mitsiades C, Raje N, Jaye DL, Kumar SK, Richardson P, Munshi N, Anderson KC. Cancer Cell. 2009 Oct 6;16(4):309-23.
Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, Fatica A, Negrini M, Peschle C, Valtieri M. Exp Hematol. 2008 Aug;36(8):1035-46.
Sadeghi M, Susal C, Daniel V, Naujokat C, Zimmermann R, Huth-Kuhne A, Opelz G. AIDS Res Hum Retroviruses. 2007 Jul;23(7):886-90.
Hatfield K, Ryningen A, Corbascio M, Bruserud O. Int J Cancer. 2006 Nov 15;119(10):2313-21.